Joachim N Nilsson

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Magnetic Resonance

Top Venues

EJNMMI research

Thyroid research

This page only lists publications with an associated author ORCID identifier.

Publications

Märta Persson, Cecilia Hindorf, Oscar Ardenfors, Martin Larsson, Joachim N Nilsson
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy. EJNMMI research 14 (1) (2024)
Märta Persson, Cecilia Hindorf, Oscar Ardenfors, Martin Larsson, Joachim N Nilsson
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy. EJNMMI research 14 (1) (2024)
Joachim N Nilsson, Per Grybäck, Carl Christofer Juhlin, Christel Hedman, Catharina Ihre Lundgren
Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer. Endocrine (2023)
Joachim N Nilsson, Rebecca Elovsson, Daniel Thor, Jan Calissendorff, Oscar Ardenfors
Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism. Thyroid research 15 (1) (2022)
Oscar Ardenfors, Joachim N Nilsson, Daniel Thor, Cecilia Hindorf
Simplified dosimetry for kidneys and tumors in 177 Lu-labeled peptide receptor radionuclide therapy. EJNMMI physics 9 (1) (2022)
Joachim N Nilsson, Jonathan Siikanen, Christel Hedman, Carl Christofer Juhlin, Catharina Ihre Lundgren
Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index. Cancers 13 (14) (2021)